Brodalumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: SILIQ

Filter by location:

New York, New York1 trial

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.